Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 48 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Prevention and Research Institute of Texas
Grant: RP190561
Cancer Prevention and Research Institute of Texas
Grant: RP150551
National Institute of Neurological Disorders and Stroke
Grant: R61NS112410
National Cancer Institute
Grant: P01CA163205
National Cancer Institute
Grant: GBM12
University of Texas System
Grant: PCT/US2018/034363
University of Texas System
Grant: US-2020-0115326-A1
University of Texas System
Grant: EU18804968.8-1109/3630189
US Department of Defense
Grant: W81XWH-18-1-0004
US Department of Defense
Grant: W81XWH-19-1-0598
Welch Foundation
Grant: AU-0042-20030616
National Institute of General Medical Sciences
Grant: R35GM138264
NINDS NIH HHS
Grant: R01 NS127473
National Institutes of Health
Grant: 3P01CA163205-03S1
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
National Institutes of Health
Grant: 5R35GM138264-04
Chemical approaches for generating blood-brain barrier-permeable antibody conjugates
National Institutes of Health
Grant: 5R61NS112410-02
Optimizing oncolytic virus therapy for glioblastoma
California Breast Cancer Research Program
Japan Society for the Promotion of Science
Mayo Clinic
National Institutes of Health
FWCI
5.87
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals